<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Pulseless_Electrical_Activity_%28PEA%29</id>
	<title>Pulseless Electrical Activity (PEA) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Pulseless_Electrical_Activity_%28PEA%29"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;action=history"/>
	<updated>2026-08-17T17:14:10Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;diff=27715&amp;oldid=prev</id>
		<title>Mfrdmanager at 13:38, 13 November 2020</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;diff=27715&amp;oldid=prev"/>
		<updated>2020-11-13T13:38:10Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:38, 13 November 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l51&quot; &gt;Line 51:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 51:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Pharmacologic Therapy:====&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Pharmacologic Therapy:====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Adrenergics&lt;/del&gt;|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Epinephrine&lt;/ins&gt;|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''OR'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''OR'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Hormones Vitamins&lt;/del&gt;|VASOPRESSIN]] 40 units IV / IO – to replace the first or second dose of epinephrine&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Vasopressin&lt;/ins&gt;|VASOPRESSIN]] 40 units IV / IO – to replace the first or second dose of epinephrine&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Vasopressin is a one-time dose&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Vasopressin is a one-time dose&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l59&quot; &gt;Line 59:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 59:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;! The current national guidelines do not include ATROPINE from treatment of TRUE PEA as there is no proof it has a therapeutic benefit. &amp;lt;br /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;! The current national guidelines do not include ATROPINE from treatment of TRUE PEA as there is no proof it has a therapeutic benefit. &amp;lt;br /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Under the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Maitland Fire Rescue &lt;/del&gt;Practice Parameters the use of ATROPINE SULFATE is indicated in cardiac arrest that may be caused by extreme bradycardia/hypotension.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Under the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Seminole County &lt;/ins&gt;Practice Parameters the use of ATROPINE SULFATE is indicated in cardiac arrest that may be caused by extreme bradycardia/hypotension.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l65&quot; &gt;Line 65:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 65:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Cases of suspected bradycardia, relative bradycardia or vagally stimulated such as patients found in the restroom.====&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Cases of suspected bradycardia, relative bradycardia or vagally stimulated such as patients found in the restroom.====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* First, [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|ATROPINE]] 0.5 -1.0 mg rapid IVP. Repeat every 3 - 5 minutes up to a total of 0.04 mg/kg or approximately 3 mg&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* First, [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Atropine&lt;/ins&gt;|ATROPINE]] 0.5 -1.0 mg rapid IVP. Repeat every 3 - 5 minutes up to a total of 0.04 mg/kg or approximately 3 mg&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Apply TCP, set at maximum Milliamp. If pulse generated, decrease dosage to setting which still maintains a palpable pulse. If unsuccessful, reattempt capture every 3 - 5 minutes as above&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Apply TCP, set at maximum Milliamp. If pulse generated, decrease dosage to setting which still maintains a palpable pulse. If unsuccessful, reattempt capture every 3 - 5 minutes as above&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Adrenergics&lt;/del&gt;|EPINEPHRINE 1:10,000]] 1 mg IVP or IO Repeat EPINEPHRINE every 3 - 5 minutes of continued arrest&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Epinephrine&lt;/ins&gt;|EPINEPHRINE 1:10,000]] 1 mg IVP or IO Repeat EPINEPHRINE every 3 - 5 minutes of continued arrest&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;diff=107&amp;oldid=prev</id>
		<title>Mfrdmanager: Protected &quot;Pulseless Electrical Activity (PEA)&quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;diff=107&amp;oldid=prev"/>
		<updated>2018-02-10T14:02:11Z</updated>

		<summary type="html">&lt;p&gt;Protected &amp;quot;&lt;a href=&quot;/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&quot; title=&quot;Pulseless Electrical Activity (PEA)&quot;&gt;Pulseless Electrical Activity (PEA)&lt;/a&gt;&amp;quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:02, 10 February 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;diff=106&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;== Section 4 - CARDIAC == === 4.04 PULSELESS ELECTRICAL ACTIVITY (PEA) ===   Pulseless Electrical Activity is a condition associated with poor outcomes. It is identified by th...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Pulseless_Electrical_Activity_(PEA)&amp;diff=106&amp;oldid=prev"/>
		<updated>2018-02-10T14:02:05Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Section 4 - CARDIAC == === 4.04 PULSELESS ELECTRICAL ACTIVITY (PEA) ===   Pulseless Electrical Activity is a condition associated with poor outcomes. It is identified by th...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Section 4 - CARDIAC ==&lt;br /&gt;
=== 4.04 PULSELESS ELECTRICAL ACTIVITY (PEA) ===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Pulseless Electrical Activity is a condition associated with poor outcomes. It is identified by the presence of cardiac electrical activity with no corresponding mechanical pulse or signs of perfusion. It is important to CONFIRM true PEA early in the management of the case. Consider all possible reversible causes for PEA utilizing a national recommended mnemonic of “H’s and T’s”:&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! H’s !! T’s&lt;br /&gt;
|-&lt;br /&gt;
| Hypovolemia|| Tension Pneumothorax&lt;br /&gt;
|-&lt;br /&gt;
| Hypoxia|| Tamponade, cardiac&lt;br /&gt;
|-&lt;br /&gt;
| Hydrogen Ion (acidosis)|| Toxins or Tablets (overdose)&lt;br /&gt;
|-&lt;br /&gt;
| Hypo/hyperkalemia|| Thrombosis, pulmonary&lt;br /&gt;
|-&lt;br /&gt;
| Hypothermia|| Thrombosis, cardiac&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
In addition, also consider the following:&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| Hypoglycemia|| Trauma&lt;br /&gt;
|}&lt;br /&gt;
'''&lt;br /&gt;
BASED ON THE MEDICAL ETIOLOGY OF PEA REFER TO APPROPRIATE PRACTICE PARAMETER:'''&lt;br /&gt;
* Hypovolemia, [[Shock|SHOCK (5.13)]].&lt;br /&gt;
* Tension Pneumothorax, [[Chest Injuries|CHEST INJURIES (6.04)]].&lt;br /&gt;
* Hypoxia / Acidosis, [[Initial Medical Assessment and Care|INITIAL MEDICAL CARE (2.01)]].&lt;br /&gt;
* Hypothermia, [[Cold Emergencies|COLD EMERGENCIES (5.06)]].&lt;br /&gt;
* Hypoglycemia, [[Hypo or Hyperglycemia|HYPO/HYPERGLYCEMIA (5.10)]]&lt;br /&gt;
* Toxins, [[Drug Overdose Poisoning|DRUG OVERDOSE/POISONING (5.05)]]&lt;br /&gt;
&lt;br /&gt;
'''''When the Patient found in True PEA:'''''&lt;br /&gt;
* Initiate 5 cycles of high quality CPR (push hard/push fast)&lt;br /&gt;
** Minimum of 100 compressions per minute, minimize interruptions&lt;br /&gt;
** Compression rate of 30:2 for approximately 2 minutes&lt;br /&gt;
** Depth of compression of at least 2 inches&lt;br /&gt;
** Initiate the use of a mechanical compression device if available&lt;br /&gt;
* Assist ventilations with OXYGEN @ 100% via BVM - DO NOT HYPERVENTILATE&lt;br /&gt;
* Establish intravenous access via IV or IO&lt;br /&gt;
* Reassess for circulation every two minutes&lt;br /&gt;
** If a shockable rhythm is identified proceed to [[Ventricular Fibrillation Pulseless Ventricular Tachycardia|VF/VT PARAMETER (4.08)]]&lt;br /&gt;
* Consider advanced airway procedure using supraglottic airway (king tube) or endotracheal intubation&lt;br /&gt;
** Do not interrupt compressions to place an advanced airway&lt;br /&gt;
** Confirm tube placement with capnography (a range 5-20 mmHg is indicative of low cardiac output)&lt;br /&gt;
* If hypovolemia suspected, administer IV fluid bolus 200 - 300 ml and reassess&lt;br /&gt;
* If HYPOTHERMIC, also follow [[Cold Emergencies|HYPOTHERMIC PARAMETER (5.06)]]&lt;br /&gt;
&lt;br /&gt;
====Pharmacologic Therapy:====&lt;br /&gt;
* [[Adrenergics|EPINEPHRINE 1:10,000]] 1 mg IV / IO – repeat every 3-5 minutes of arrest&lt;br /&gt;
'''OR'''&lt;br /&gt;
* [[Hormones Vitamins|VASOPRESSIN]] 40 units IV / IO – to replace the first or second dose of epinephrine&lt;br /&gt;
** Vasopressin is a one-time dose&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! The current national guidelines do not include ATROPINE from treatment of TRUE PEA as there is no proof it has a therapeutic benefit. &amp;lt;br /&amp;gt;&lt;br /&gt;
Under the Maitland Fire Rescue Practice Parameters the use of ATROPINE SULFATE is indicated in cardiac arrest that may be caused by extreme bradycardia/hypotension.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''''Check for pulse and rhythm change after all interventions.'''''&lt;br /&gt;
&lt;br /&gt;
====Cases of suspected bradycardia, relative bradycardia or vagally stimulated such as patients found in the restroom.====&lt;br /&gt;
* First, [[Antiarrhythmics|ATROPINE]] 0.5 -1.0 mg rapid IVP. Repeat every 3 - 5 minutes up to a total of 0.04 mg/kg or approximately 3 mg&lt;br /&gt;
* Apply TCP, set at maximum Milliamp. If pulse generated, decrease dosage to setting which still maintains a palpable pulse. If unsuccessful, reattempt capture every 3 - 5 minutes as above&lt;br /&gt;
* [[Adrenergics|EPINEPHRINE 1:10,000]] 1 mg IVP or IO Repeat EPINEPHRINE every 3 - 5 minutes of continued arrest&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''''If patient combative post resuscitation, refer to [[Analgesia and Sedation|ANALGESIA /SEDATION PARAMETER (2.04)]].'''''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Termination of Resuscitation:====&lt;br /&gt;
In Medical Related Cardiac Arrests, the paramedic may terminate resuscitative efforts in Non-Hypothermic Adults provided all of the following criteria have been provided and established:&lt;br /&gt;
* Patient initially presents and maintains PEA&lt;br /&gt;
* Airway has been successfully controlled (not necessarily intubated)&lt;br /&gt;
* If clinically indicated - ATROPINE SULFATE 1.0 mg rapid IVP/ IO has been administered and allowed time to circulate x1.&lt;br /&gt;
* EPINEPHRINE 1:10,000 1 mg IVP or IO has been administered &amp;amp; allowed time to circulate x1, or&lt;br /&gt;
* VASOPRESSIN 40 units IVP has been administered and allowed time to circulate. x1&lt;br /&gt;
* EtCO2 is (less than) &amp;lt; 20 mm Hg&lt;br /&gt;
* Efforts to verify akinetic heart have been taken&lt;br /&gt;
** Lack of Heart sounds&lt;br /&gt;
** Rule out of H's and T's&lt;br /&gt;
'''OR'''&lt;br /&gt;
* After 15 minutes of ALS procedures without any response or return of spontaneous circulation&lt;br /&gt;
'''OR'''&lt;br /&gt;
* After the patient’s personal medical doctor agrees to sign the death certificate&lt;br /&gt;
'''''Contact will be made in conjunction and compliance with Federal, State, Local, and Agency Laws and Policies regarding patient body care and removal.'''''&lt;br /&gt;
&amp;lt;br /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''''A paramedic may decide to continue resuscitation efforts as outlined in these Practice Parameters. Reasons to continue may include scene safety, location, and input from present family members.'''''&lt;br /&gt;
&lt;br /&gt;
[[Category:Cardiac|0404]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>